SCHEMBL6130488

SCHEMBL6130488

O=C(O)CCCCNc1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.61
ALDH1A1 P00352 2/20 0.61
HDAC1 Q13547 6/20 0.56
HDAC3 O15379 3/20 0.56
HDAC2 Q92769 3/20 0.56
NCOR2 Q9Y618 1/20 0.56
TBXA2R P21731 1/20 0.53
CDC25A P30304 2/20 0.53
CDC25B P30305 2/20 0.53
FFAR1 O14842 1/20 0.51
MAPK1 P28482 2/20 0.50
HDAC4 P56524 2/20 0.50
HDAC7 Q8WUI4 2/20 0.50
HDAC10 Q969S8 2/20 0.50
HDAC11 Q96DB2 2/20 0.50
HDAC8 Q9BY41 2/20 0.50
HDAC6 Q9UBN7 2/20 0.50
HDAC9 Q9UKV0 2/20 0.50
HDAC5 Q9UQL6 2/20 0.50
RXFP1 Q9HBX9 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19816482 0.98 ALDH1A1 (0.59) MAPTALDH1A1HDAC1HDAC3HDAC2
SCHEMBL859720 0.98 ALDH1A1 (0.59) MAPTALDH1A1HDAC1HDAC3HDAC2
SCHEMBL8390655 0.98 ALDH1A1 (0.59) MAPTALDH1A1HDAC1HDAC3HDAC2
SCHEMBL16691726 0.98 ALDH1A1 (0.59) MAPTALDH1A1HDAC1HDAC3HDAC2
SCHEMBL19816825 0.98 ALDH1A1 (0.59) MAPTALDH1A1HDAC1HDAC3HDAC2
SCHEMBL15068944 0.98 ALDH1A1 (0.59) MAPTALDH1A1HDAC1HDAC3HDAC2
SCHEMBL4624978 0.98 ALDH1A1 (0.59) MAPTALDH1A1HDAC1HDAC3HDAC2
Water SCHEMBL28193859 0.96 HDAC1 (0.57) MAPTALDH1A1HDAC1HDAC3HDAC2
SCHEMBL2177141 0.94 ALDH1A1 (0.64) MAPTALDH1A1HDAC1HDAC3HDAC2
SCHEMBL27609848 0.92 ALDH1A1 (0.61) MAPTALDH1A1HDAC1HDAC3HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108516941-A A kind of 3-(Phenyl amino)The preparation method of ethyl propionate class compound 济南大学 2018-09-11 CN claimed
EP-1416934-A4 PROTEIN KINASE INHIBITORS COMPRISING ATP MIMETICS CONJUGATED TO PEPTIDES OR PEPTIDOMIMETICS PEPTOR LTD (IL) 2005-11-02 EP claimed
EP-1416934-A2 PROTEIN KINASE INHIBITORS COMPRISING ATP MIMETICS CONJUGATED TO PEPTIDES OR PEPTIDOMIMETICS Peptor Ltd. (IL) 2004-05-12 EP claimed
WO-2003010281-A2 PROTEIN KINASE INHIBITORS COMPRISING ATP MIMETICS CONJUGATED TO PEPTIDES OR PEPTIDOMIMETICS PEPTOR LTD. (IL) 2003-02-06 WO claimed
CN-117362188-A Synthesis method of alpha-substituted deuterated amino acid ester 广州医科大学 2024-01-09 CN disclosed
CN-110234631-A For treating the composition of hypertension and/or fibrosis 维克特斯生物系统有限公司 2019-09-13 CN disclosed
EP-3488000-A1 METHODS AND MATERIALS FOR BIOSYNTHESIZING MULTIFUNCTIONAL, MULTIVARIATE MOLECULES VIA CARBON CHAIN MODIFICATION INVISTA Textiles (U.K.) Limited (GB) 2019-05-29 EP disclosed
CN-108516941-A A kind of 3-(Phenyl amino)The preparation method of ethyl propionate class compound 济南大学 2018-09-11 CN disclosed
WO-2018022633-A1 METHODS AND MATERIALS FOR BIOSYNTHESIZING MULTIFUNCTIONAL, MULTIVARIATE MOLECULES VIA CARBON CHAIN MODIFICATION INVISTA TEXTILES (U.K.) LIMITED (GB) 2018-02-01 WO disclosed
EP-3126006-A1 ANTI-EGFR ANTIBODIES AND ANTIBODY DRUG CONJUGATES AbbVie Inc. (US) 2017-02-08 EP disclosed
CN-103524559-B Ester derivant of polysubstituted 4-methylamino benzenecarboximidamide and its production and use 西藏海思科药业集团股份有限公司 2016-09-28 CN disclosed
CN-105439945-A Aryloxy anilino propionic ester compound and application thereof as herbicide UNIV YANGTZE 2016-03-30 CN disclosed
WO-2015143382-A1 ANTI-EGFR ANTIBODIES AND ANTIBODY DRUG CONJUGATES ABBVIE INC. (US) 2015-09-24 WO disclosed
CN-103524559-A Ester derivatives of multi-substituted 4-methylamino-benzamidine as well as preparation method and application of ester derivatives TIBET HAISCO PHARMACEUTICAL GROUP CO LTD 2014-01-22 CN disclosed
WO-2008007391-A2 AN IMPROVED PROCESS FOR THE PREPARATION OF VALSARTAN SATYANARAYANA REDDY MANNE (IN) 2008-01-17 WO disclosed